{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T19:30:15Z","timestamp":1760729415617},"reference-count":53,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"published-print":{"date-parts":[[2002,10]]},"DOI":"10.1053\/beog.2002.0313","type":"journal-article","created":{"date-parts":[[2002,12,11]],"date-time":"2002-12-11T01:48:30Z","timestamp":1039571310000},"page":"703-713","source":"Crossref","is-referenced-by-count":11,"title":["Hereditary risk of women's cancers"],"prefix":"10.1053","volume":"16","author":[{"given":"Thomas S.","family":"Frank","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory C.","family":"Critchfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/beog.2002.0313_RF1","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2318::AID-CNCR21>3.0.CO;2-Z","article-title":"The genetic attributable risk of breast and ovarian cancer","volume":"77","author":"Claus","year":"1996","journal-title":"Cancer"},{"key":"10.1053\/beog.2002.0313_RF2","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1086\/318787","article-title":"Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer","volume":"68","author":"Risch","year":"2001","journal-title":"American Journal of Human Genetics"},{"key":"10.1053\/beog.2002.0313_RF3","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","article-title":"Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families","volume":"62","author":"Ford","year":"1998","journal-title":"American Journal of Human Genetics"},{"key":"10.1053\/beog.2002.0313_RF4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0092-8674(00)81847-4","article-title":"Association of BRCA1 with Rad51 in mitotic and meiotic cells","volume":"88","author":"Scully","year":"1997","journal-title":"Cell"},{"key":"10.1053\/beog.2002.0313_RF5","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/386804a0","article-title":"Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking BRCA2","volume":"386","author":"Sharan","year":"1997","journal-title":"Nature"},{"key":"10.1053\/beog.2002.0313_RF6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nm0296-169","article-title":"Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients","volume":"2","author":"Liu","year":"1996","journal-title":"Nature Medicine"},{"key":"10.1053\/beog.2002.0313_RF7","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1126\/science.278.5340.1043","article-title":"Human cancer syndromes: clues to the origin and nature of cancer","volume":"278","author":"Fearon","year":"1997","journal-title":"Science"},{"key":"10.1053\/beog.2002.0313_RF8","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0140-6736(94)91578-4","article-title":"Risks of cancer in BRCA1 -mutation carriers","volume":"343","author":"Ford","year":"1994","journal-title":"Lancet"},{"key":"10.1053\/beog.2002.0313_RF9","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199705153362001","article-title":"The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews","volume":"336","author":"Struewing","year":"1997","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beog.2002.0313_RF10","first-page":"265","article-title":"Breast and ovarian cancer incidence in BRCA1 -mutation carriers","volume":"56","author":"Easton","year":"1995","journal-title":"American Journal of Human Genetics"},{"key":"10.1053\/beog.2002.0313_RF11","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0140-6736(97)07065-7","article-title":"Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1","volume":"351","author":"Verhoog","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/beog.2002.0313_RF12","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/jnci\/91.15.1310","volume":"91","year":"1999","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1053\/beog.2002.0313_RF13","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1200\/JCO.1999.17.11.3396","article-title":"Survival in hereditary breast cancer associated with germline mutations of Brca2","volume":"17","author":"Verhoog","year":"1999","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beog.2002.0313_RF14","first-page":"496","article-title":"Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three U.S. population-based case-control studies of ovarian cancer","volume":"60","author":"Whittemore","year":"1997","journal-title":"American Journal of Human Genetics"},{"key":"10.1053\/beog.2002.0313_RF15","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1200\/JCO.1998.16.7.2417","article-title":"Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk","volume":"16","author":"Frank","year":"1998","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beog.2002.0313_RF16","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1006\/gyno.2000.6082","article-title":"Risk of endometrial carcinoma associated with BRCA mutation","volume":"80","author":"Levine","year":"2001","journal-title":"Gynecologic Oncology"},{"key":"10.1053\/beog.2002.0313_RF17","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/BF02236700","article-title":"Colorectal cancer in hereditary breast cancer kindreds","volume":"42","author":"Lin","year":"1999","journal-title":"Diseases of the Colon and Rectum"},{"key":"10.1053\/beog.2002.0313_RF18","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1053\/gast.1996.v110.pm8612988","article-title":"Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis","volume":"110","author":"Vasen","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1053\/beog.2002.0313_RF19","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.0.CO;2-L","article-title":"Cancer risk in mutation carriers of DNA-mismatch-repair genes","volume":"81","author":"Aarnio","year":"1999","journal-title":"International Journal of Cancer"},{"key":"10.1053\/beog.2002.0313_RF20","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/1097-0142(197710)40:4+<1849::AID-CNCR2820400813>3.0.CO;2-U","article-title":"Role of heredity in multiple primary cancer","volume":"40","author":"Lynch","year":"1977","journal-title":"Cancer"},{"key":"10.1053\/beog.2002.0313_RF21","first-page":"847","article-title":"Histopathology of colorectal carcinomas and adenomas in cancer family syndrome","volume":"29","author":"Mecklin","year":"1986","journal-title":"Diseases of the Colon and Rectum"},{"key":"10.1053\/beog.2002.0313_RF22","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1001\/jama.1997.03540360065034","article-title":"Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 andBRCA2","volume":"277","author":"Burke","year":"1997","journal-title":"Journal of the American Medical Association"},{"key":"10.1053\/beog.2002.0313_RF23","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1093\/jnci\/93.14.1095","article-title":"Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer","volume":"93","author":"Stoutjesdijk","year":"2001","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1053\/beog.2002.0313_RF24","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study","volume":"90","author":"Fisher","year":"1998","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1053\/beog.2002.0313_RF25","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/S0140-6736(00)03258-X","article-title":"Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study","volume":"356","author":"Narod","year":"2000","journal-title":"Lancet"},{"key":"10.1053\/beog.2002.0313_RF26","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1001\/jama.286.18.2251","article-title":"Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2","volume":"286","author":"King","year":"2001","journal-title":"Journal of the American Medical Association"},{"key":"10.1053\/beog.2002.0313_RF27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJM200107193450301","article-title":"Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation [see comments]","volume":"345","author":"Meijers-Heijboer","year":"2001","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beog.2002.0313_RF28","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/jnci\/93.21.1633","article-title":"Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers","volume":"93","author":"Hartmann","year":"2001","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1053\/beog.2002.0313_RF29","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1001\/jama.1996.03530480027036","article-title":"BRCA1 testing in families with hereditary breast-ovarian cancer. Aprospective study of patient decision making and outcomes","volume":"275","author":"Lerman","year":"1996","journal-title":"Journal of the American Medical Association"},{"key":"10.1053\/beog.2002.0313_RF30","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1001\/jama.1995.03520300065039","volume":"273","year":"1995","journal-title":"Journal of the American Medical Association"},{"key":"10.1053\/beog.2002.0313_RF31","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJM199808133390702","article-title":"Oral contraceptives and the risk of hereditary ovarian cancer","volume":"339","author":"Narod","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beog.2002.0313_RF32","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(00)04642-0","article-title":"Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study","volume":"357","author":"Narod","year":"2001","journal-title":"Lancet"},{"key":"10.1053\/beog.2002.0313_RF33","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJM200107263450401","article-title":"Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 orBRCA2 mutation","volume":"345","author":"Modan","year":"2001","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beog.2002.0313_RF34","first-page":"59","article-title":"Ovarian cancer risk reduction after bilateral prophylactic oophorectomy (BPO) in BRCA1 andBRCA2 mutation carriers","volume":"67","author":"Weber","year":"2000","journal-title":"American Journal of Human Genetics"},{"key":"10.1053\/beog.2002.0313_RF35","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/jnci\/91.17.1475","article-title":"Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers","volume":"91","author":"Rebbeck","year":"1999","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1053\/beog.2002.0313_RF36","doi-asserted-by":"crossref","unstructured":"Burke, W, Petersen, G, Lynch, P, Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer, Cancer Genetics Studies Consortium, New England Journal of Medicine, 277, 915, 919","DOI":"10.1001\/jama.277.11.915"},{"key":"10.1053\/beog.2002.0313_RF37","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1006\/gyno.2000.6065","article-title":"Cancer risk in young women at risk of hereditary nonpolyposis colorectal cancer: implications for gynecologic surveillance","volume":"80","author":"Brown","year":"2001","journal-title":"Gynecologic Oncology"},{"key":"10.1053\/beog.2002.0313_RF38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00001703-200002000-00005","article-title":"Surveillance of the endometrium in tamoxifen treated women","volume":"12","author":"Cardosi","year":"2000","journal-title":"Current Opinion in Obstetrics and Gynecology"},{"key":"10.1053\/beog.2002.0313_RF39","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1200\/JCO.2000.18.20.3459","article-title":"Effect of adjuvant tamoxifen on the endometrium in women with breast cancer: a prospective study using office endometrial biopsy","volume":"18","author":"Barakat","year":"2000","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beog.2002.0313_RF40","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0016-5085(00)70168-5","article-title":"Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer","volume":"118","author":"Jarvinen","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1053\/beog.2002.0313_RF41","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/BF02234829","article-title":"Limitations of family cancer history assessment at initial surgical consultation","volume":"44","author":"Ruo","year":"2001","journal-title":"Diseases of the Colon and Rectum"},{"key":"10.1053\/beog.2002.0313_RF42","first-page":"107","article-title":"Screening your patients for inherited breast and ovarian cancer: how to collect family history data","volume":"43","author":"Huelsman","year":"1998","journal-title":"Contemporary Ob\/Gyn"},{"key":"10.1053\/beog.2002.0313_RF43","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1200\/JCO.20.6.1480","article-title":"Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals","volume":"20","author":"Frank","year":"2002","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beog.2002.0313_RF44","first-page":"505","article-title":"The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women","volume":"60","author":"Abeliovich","year":"1997","journal-title":"American Journal of Human Genetics"},{"key":"10.1053\/beog.2002.0313_RF45","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/jnci\/91.14.1241","article-title":"Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer","volume":"91","author":"Warner","year":"1999","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1053\/beog.2002.0313_RF46","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1006\/gyno.1997.4844","article-title":"High frequency of BRCA1 and BRCA2 germline mutations in Ashkenazi Jewish ovarian cancer patients, regardless of family history","volume":"67","author":"Beller","year":"1997","journal-title":"Gynecologic Oncology"},{"key":"10.1053\/beog.2002.0313_RF47","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/jmg.37.9.641","article-title":"Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations inMSH2 and MLH1","volume":"37","author":"Syngal","year":"2000","journal-title":"Journal of Medical Genetics"},{"key":"10.1053\/beog.2002.0313_RF48","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1053\/gast.2001.25580","volume":"121","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1053\/beog.2002.0313_RF49","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1136\/jmg.38.12.824","article-title":"Blinded comparison of methods for detecting germline BRCA1 mutations: implications for molecular epidemiologic research and the practice of molecular medicine","volume":"38","author":"Eng","year":"2001","journal-title":"Journal of Medical Genetics"},{"key":"10.1053\/beog.2002.0313_RF50","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1126\/science.278.5340.1050","article-title":"Genetic testing for cancer risk","volume":"278","author":"Ponder","year":"1997","journal-title":"Science"},{"key":"10.1053\/beog.2002.0313_RF51","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1089\/109065700316462","article-title":"The predictive value of BRCA1 and BRCA2 mutation testing","volume":"4","author":"Bansal","year":"2000","journal-title":"Genetic Testing"},{"key":"10.1053\/beog.2002.0313_RF52","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1200\/JCO.1998.16.5.1650","article-title":"What you don't know can hurt you: adverse psychologic effects in members of BRCA1 -linked andBRCA2 -linked families who decline genetic testing","volume":"16","author":"Lerman","year":"1998","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beog.2002.0313_RF53","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1200\/JCO.20.2.514","article-title":"Impact of BRCA1 \/ BRCA2 mutation testing on psychologic distress in a clinic-based sample","volume":"20","author":"Schwartz","year":"2002","journal-title":"Journal of Clinical Oncology"}],"container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693402903135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693402903135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T15:53:54Z","timestamp":1583942034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693402903135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,10]]}},"alternative-id":["S1521693402903135"],"URL":"https:\/\/doi.org\/10.1053\/beog.2002.0313","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2002,10]]}}}